Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,409,760
  • Shares Outstanding, K 35,430
  • Annual Sales, $ 386,910 K
  • Annual Income, $ -131,360 K
  • 60-Month Beta 0.79
  • Price/Sales 3.56
  • Price/Cash Flow N/A
  • Price/Book 4.26
Trade NVRO with:

Options Overview Details

View History
  • Implied Volatility 67.23% ( +4.13%)
  • Historical Volatility 41.76%
  • IV Percentile 56%
  • IV Rank 43.95%
  • IV High 92.35% on 05/02/22
  • IV Low 47.53% on 08/10/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 272
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 8,041
  • Open Int (30-Day) 7,712

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.49
  • Number of Estimates 9
  • High Estimate -0.43
  • Low Estimate -0.56
  • Prior Year -0.86
  • Growth Rate Est. (year over year) +43.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.89 +14.04%
on 01/12/23
41.71 -4.59%
on 01/04/23
+0.07 (+0.18%)
since 01/03/23
3-Month
34.89 +14.04%
on 01/12/23
48.10 -17.28%
on 12/01/22
-1.90 (-4.56%)
since 11/03/22
52-Week
34.70 +14.67%
on 10/11/22
78.90 -49.57%
on 04/05/22
-21.65 (-35.24%)
since 02/03/22

Most Recent Stories

More News
Strength Seen in Nevro (NVRO): Can Its 5.1% Jump Turn into More Strength?

Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

NVRO : 39.79 (+1.92%)
GMED : 79.63 (+1.32%)
Thermo Fisher Scientific (TMO) Surpasses Q4 Earnings and Revenue Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 4.05% and 10.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TMO : 587.76 (+0.12%)
NVRO : 39.79 (+1.92%)
Nevro Named to 2023 Bloomberg Gender-Equality Index for Second Consecutive Year

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 39.79 (+1.92%)
Here's Why You Should Retain Nevro (NVRO) Stock for Now

Investors continue to be optimistic about Nevro (NVRO), owing to its R&D edge.

CAH : 78.67 (+3.13%)
MMSI : 73.33 (-0.12%)
AMN : 103.87 (+1.44%)
NVRO : 39.79 (+1.92%)
Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 39.79 (+1.92%)
Nevro to Highlight New Clinical Evidence at the 2023 North American Neuromodulation Society (NANS) 26th Annual Meeting

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 39.79 (+1.92%)
Nevro's (NVRO) Preliminary Q4 Revenues Solid, Issues '23 Outlook

Nevro's (NVRO) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its PDN business.

CAH : 78.67 (+3.13%)
MMSI : 73.33 (-0.12%)
AMN : 103.87 (+1.44%)
NVRO : 39.79 (+1.92%)
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2022 Revenue and Provides Full-Year 2023 Revenue Guidance

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 39.79 (+1.92%)
3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio

Investors continue to be optimistic about Nevro (NVRO), owing to its R&D edge.

MMSI : 73.33 (-0.12%)
EXAS : 67.45 (-4.69%)
NVRO : 39.79 (+1.92%)
SWAV : 187.32 (-1.15%)
Nevro to Present at 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...

NVRO : 39.79 (+1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation...

See More

Key Turning Points

3rd Resistance Point 42.07
2nd Resistance Point 41.05
1st Resistance Point 40.42
Last Price 39.79
1st Support Level 38.77
2nd Support Level 37.75
3rd Support Level 37.12

See More

52-Week High 78.90
Fibonacci 61.8% 62.02
Fibonacci 50% 56.80
Fibonacci 38.2% 51.58
Last Price 39.79
52-Week Low 34.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar